Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart Diseases: JACC Guideline Comparison.
Coisne A, Lancellotti P, Habib G, Garbi M, Dahl JS, Barbanti M, Vannan MA, Vassiliou VS, Dudek D, Chioncel O, Waltenberger JL, Johnson VL, De Paulis R, Citro R, Pibarot P; EuroValve Consortium. Coisne A, et al. Among authors: waltenberger jl. J Am Coll Cardiol. 2023 Aug 22;82(8):721-734. doi: 10.1016/j.jacc.2023.05.061. J Am Coll Cardiol. 2023. PMID: 37587584 Free article. Review.
Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year data from the ETNA-AF-Europe study.
Kirchhof P, Bakhai A, de Asmundis C, de Groot JR, Deharo JC, Kelly P, Lopez-de-Sa E, Monteiro P, Fronk EM, Lamparter M, Laeis P, Smolnik R, Steffel J, Waltenberger J, Weiss TW, De Caterina R; ETNA-AF-Europe investigators. Kirchhof P, et al. Int J Cardiol. 2024 Apr 30;408:132118. doi: 10.1016/j.ijcard.2024.132118. Online ahead of print. Int J Cardiol. 2024. PMID: 38697397 Free article.
Contemporary rationale for non-invasive imaging of adverse coronary plaque features to identify the vulnerable patient: a Position Paper from the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology and the European Association of Cardiovascular Imaging.
Dweck MR, Maurovich-Horvat P, Leiner T, Cosyns B, Fayad ZA, Gijsen FJH, Van der Heiden K, Kooi ME, Maehara A, Muller JE, Newby DE, Narula J, Pontone G, Regar E, Serruys PW, van der Steen AFW, Stone PH, Waltenberger JL, Yuan C, Evans PC, Lutgens E, Wentzel JJ, Bäck M. Dweck MR, et al. Among authors: waltenberger jl. Eur Heart J Cardiovasc Imaging. 2020 Oct 20;21(11):1177-1183. doi: 10.1093/ehjci/jeaa201. Eur Heart J Cardiovasc Imaging. 2020. PMID: 32887997
Thrombin generation in patients with a first acute myocardial infarction.
Smid M, Dielis AW, Winkens M, Spronk HM, van Oerle R, Hamulyák K, Prins MH, Rosing J, Waltenberger JL, ten Cate H. Smid M, et al. Among authors: waltenberger jl. J Thromb Haemost. 2011 Mar;9(3):450-6. doi: 10.1111/j.1538-7836.2010.04162.x. J Thromb Haemost. 2011. PMID: 21143375 Free article.
Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.
Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Shah PK, Tardif JC, Chaitman BR, Duttlinger-Maddux R, Mathieson J; dal-OUTCOMES Committees and Investigators. Schwartz GG, et al. Am Heart J. 2009 Dec;158(6):896-901.e3. doi: 10.1016/j.ahj.2009.09.017. Am Heart J. 2009. PMID: 19958854 Clinical Trial.